Literature DB >> 3760462

Serum levels of calcitonin in Cushing's syndrome.

G Luisetto, F Mantero, M Boscaro, L Tizian, M Zangari, D Ziliotto.   

Abstract

Serum levels of calcitonin (CT) were studied in 21 patients with Cushing's syndrome (CS), 18 females and 3 males aging from 16 to 59 years, and in 70 age and sex matched normal subjects. Patients with CS showed CT values significantly lower than those found in controls (9.9 +/- 5.0 pg/ml vs. 15.9 +/- 6.3 pg/ml, mean +/- SD; p less than 0.01), while no difference was observed in total serum calcium and phosphate and calcium corrected for albumin. No correlation between CT and serum calcium and phosphate, serum cortisol and urinary free cortisol was found. It is possible that low CT levels are involved in the pathogenesis of bone loss observed in CS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3760462     DOI: 10.1007/BF03348108

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  18 in total

1.  Effect of glucocorticoids on function of the parathyroid glands in man.

Authors:  R F Fucik; S C Kukreja; G K Hargis; E N Bowser; W J Henderson; G A Williams
Journal:  J Clin Endocrinol Metab       Date:  1975-01       Impact factor: 5.958

2.  Effect of 25-hydroxycholecalciferol (25-HCC) on intestinal absorption of 47Ca in four cases of iatrogenic Cushing's syndrome.

Authors:  A Caniggia; C Gennari
Journal:  Helv Med Acta       Date:  1973-10

3.  Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass.

Authors:  T J Hahn; V C Boisseau; L V Avioli
Journal:  J Clin Endocrinol Metab       Date:  1974-08       Impact factor: 5.958

4.  Hydroxyproline excreted in the urine: its source from collagen of tissues after 14C-proline in rats with and without administration of prednisone.

Authors:  A C Kibrick; K D Singh
Journal:  J Clin Endocrinol Metab       Date:  1974-04       Impact factor: 5.958

5.  Suppressive effect of chronic glucocorticoid treatment on circulating calcitonin in man.

Authors:  V LoCascio; S Adami; L V Avioli; L Cominacini; G Galvanini; C Gennari; B Imbimbo; L A Scuro
Journal:  Calcif Tissue Int       Date:  1982-05       Impact factor: 4.333

6.  Vitamin D metabolites and parathyroid hormone in Cushing's syndrome: relationship to calcium and phosphorus homeostasis.

Authors:  J W Findling; N D Adams; J Lemann; R W Gray; C J Thomas; J B Tyrrell
Journal:  J Clin Endocrinol Metab       Date:  1982-05       Impact factor: 5.958

7.  Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae.

Authors:  E Canalis
Journal:  Endocrinology       Date:  1983-03       Impact factor: 4.736

8.  Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man.

Authors:  J J Body; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

9.  Relative deficiency of plasma-calcitonin in normal women.

Authors:  C J Hillyard; J C Stevenson; I MacIntyre
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

10.  Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess.

Authors:  E Seeman; R Kumar; G G Hunder; M Scott; H Heath; B L Riggs
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.